Latest West syndrome Stories
The first drug to treat infantile spasms has received approval from the U.S. Food and Drug Administration, the agency announced Friday. Sabril can now be used to treat the spasms, which typically occur in children ages 1 month to 2 years and are characterized by a severe type of seizure. The drug also can be used by adults in combination with other medications to treat seizures that do not respond adequately to other drug therapies, the FDA said. Children with the spams tend to suddenly...
UNION CITY, Calif., July 27 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it has joined with the Child Neurology Foundation (CNF) to officially support the creation of Infantile Spasms (IS) Awareness Week. The first annual IS Awareness Week will take place the week of October 11-17, 2009, in conjunction with the Child Neurology Society (CNS) Annual Meeting in Louisville, Kentucky, October 14-17, 2009. "Questcor is very passionate about working...
U.S. scientists have created a line of genetically engineered mice that experience seizures similar to infantile spasms so that new treatments can be tested. Children's Hospital of Philadelphia researchers said approximately 1 of 100 infants experience the difficult-to-treat form of childhood epilepsy called infantile spasms. Many of them go on to develop epilepsy. Dr. Jeffrey Golden, who led the study, said one obstacle to developing better therapies for children has been the lack of a good...
PHILADELPHIA, June 1 /PRNewswire-USNewswire/ -- Researchers studying a difficult-to-treat form of childhood epilepsy called infantile spasms have developed a line of mice that experiences seizures with features closely resembling those occurring in patients with infantile seizures. These genetically engineered mice provide a new opportunity for scientists to test treatments that may benefit children. "Approximately one out of every 100 infants has a seizure. Many of them go on to have...
Researchers studying a difficult-to-treat form of childhood epilepsy called infantile spasms have developed a line of mice that experiences seizures with features closely resembling those occurring in patients with infantile seizures. These genetically engineered mice provide a new opportunity for scientists to test treatments that may benefit children.Approximately one out of every 100 infants has a seizure. Many of them go on to have epilepsy"”characterized by recurrent seizures. One...
The antiepileptic drug vigabatrin (VGB) has been shown to be one of the best treatments against a special form of epilepsy in infants, called infantile spasm. However, its use has been limited in many countries because it has been shown to cause a permanent narrowing of visual fields in approximately 40 percent of adults who have been exposed at school age or later. A new study published in Epilepsia examined school-aged children who had been treated with VGB in infancy. The findings showed...
BRANFORD, Conn., Oct. 7 /PRNewswire/ -- Marinus Pharmaceuticals, a developer of specialty therapeutics to treat neurological and psychiatric disorders, today announced that it has completed its Phase 2 clinical trial of ganaxolone for the treatment of infantile spasms (also called West syndrome) and that the final patient has completed enrollment for its Phase 2 clinical trial of ganaxolone for the treatment of adult partial complex seizures. "Completion of the infantile spasms study and the...
U.S. scientists say they have determined a ketogenic -- or high fat, low carbohydrate -- diet is effective in treating infantile epileptic spasms. Infantile spasms are a potentially devastating epileptic condition affecting children aged 4-8 months. Johns Hopkins University researchers said their finding is the first description of the ketogenic diet as a first-line defense for infantile spasms in place of drugs. The diet is more traditionally used for intractable childhood epilepsy,...
